Interleukin‐6 production in human fibroblasts derived from periodontal tissues is differentially regulated by cytokines and a glucocorticoid

Authors:

Abstract
Interleukin‐6 (IL‐6) is thought to be a major mediator of the host's defense against infection, and it regulates immune responses in inflamed tissue. In this study, we investigated the regulation of IL‐6 production in human gingival fibroblasts (HGF) and human periodontal ligament fibroblasts (HPLF). Pro‐inflammatory cytokines including interleukin (IL)‐lα, IL‐1β and tumor necrosis factor (TNF)‐α stimulated IL‐6 production in HGF and HPLF in a time‐ and dose‐dependent manner. This IL‐lα, IL‐lβ, or TNF‐α‐induced IL‐6 production was enhanced, but the cAMP accumulation they induced was inhibited by the addition of indomethacin. This result suggests that endogenous prostaglandin E2 (PGE2) partially inhibits IL‐l or TNF‐α‐induced IL‐6 production, and that the enhancement of IL‐6 production by IL‐l or TNF‐α may not be caused through endogenous PGE2‐induced cAMP‐dependent pathway. Dexamethasone (DEX), a glucocorticoid which is a inhibitor of nuclear factor kappa B (NF‐kB) activation, markedly inhibited IL‐l (α or β) or TNF‐α‐induced IL‐6 production; so this production may be partially mediated through NF‐kB. IL‐l (α or β) and TNF‐α enhanced IL‐6 production synergistically. IL‐6 production in HGF or HPLF stimulated with IL‐lβ was augmented by the addition of interferon (IFN)‐(gama), but was slightly suppressed by the addition of IL‐4. Endogenous IL‐6 enhanced IL‐l (α or β)‐induced IL‐6 production in the presence of IL‐6 soluble receptor (IL‐6sR). Accordingly, in inflamed periodontal tissues, gingival fibroblasts and periodontal ligament fibroblasts stimulated with pro‐inflammatory cytokines such as IL‐l or TNF‐α, may produce IL‐6, and this production can be differentially modulated by endogenous PGE2, IL‐6sR, T cell‐derived cytokines such as IFN‐(gama) or IL‐4, and glucocorticoids.

This publication has 39 references indexed in Scilit: